Preclinical Research


During the preclinical stage, studies in animal models are combined with cellular and biochemical assays to understand the effects of lead drug candidates and provide detailed reporting on the pharmacological profile, acute toxicity in at least two animal species, and short-term toxicity studies. Early dosage studies are also performed to guide the implementation of subsequent clinical phases. Show more

Testing includes the pharmacology of absorption, distribution, metabolism, and excretion (ADME), metabolic stability, pharmacokinetics, immunogenicity/ADA, biomarker analysis, and the mutagenicity, reproductive effects, and in vitro and in vivo toxicity of candidates and their metabolites. Data from this phase are used to determine whether to proceed to human testing, and the no observable adverse effect levels (NOAELs) are used to guide starting dosages in clinical trials. Show less

Page Contents
Feature Article and Video

Bio-Rad's Drug Discovery and Development Workflow Solutions
Learn how Bio-Rad's products align with your drug discovery and development workflows  Download

Development of Recombinant Antibodies for PK/PD and Immunogenicity Assays 
Watch Video

Solutions for Preclinical Research

Gene Expression

Gene Expression

Rapidly evaluate responses in metabolic, signaling, and other biological pathways and characterize mutagenesis with Droplet Digital™ PCR Assays and automated real-time PCR systems and ddPCR™ Systems.

Droplet Digital PCR Systems
Real-Time PCR Automation

PCR Instrument Validation Tools and Services


Protein Purification and Analysis

Protein Purification

Develop large-scale purification strategies for your protein or antibody drug using our range of chromatography resins (media).

NGC™ Medium-Pressure Chromatography Systems
Chromatography Columns and Resins

Protein Expression

Protein Analysis

Explore our tools and assays for the identification, and analysis of protein profiles to support ADME and biomarker studies.

Multiplex Cancer Immunoassays
Western Blotting Reagents and Equipment

Cell Analysis

Cell Analysis

View changes in cell phenotype upon introduction of a drug using our advanced cell analysis systems. Develop robust cell-based screening assays using our fast, highly sensitive cell counting, cell sorting, and flow cytometry instrumentation. Our comprehensive range of antibodies and custom options allows you to monitor safety, ADME, and toxicity with ease.

Cell Imaging
Cell Counting
Cell Sorting and Flow Cytometers
Antibodies for Flow Cytometry



Choose from an extensive range of antibodies for use in your preclinical testing assays or utilize our custom antibody services.

Antibodies by Application
Antibodies by Target Species
Cell Signaling Antibodies
HuCAL® Custom Antibody Services

Additional Methodolgies and Research Within Drug Discovery and Development
  • Biochemical and Cellular Assays

    Biochemical and Cellular Assays
    In vitro and in vivo discovery approaches with high sample throughput and high-content analysis to characterize biological responses.

  • Biomarker Discovery

    Biomarker Discovery & Validation
    Biomarker monitoring across drug discovery, development, and clinical stages is key to defining drug effects.

  • Biologic Development

    Biologic Development
    Biologic development brings patients closer to personalized medicine to treat health problems.

  • Biosimilar Development

    Biosimilar Development
    Biosimilar development requires physicochemical and functional characterization to ensure similarity.

  • Cancer Immunotherapy Development

    Cancer Immunotherapy Development
    Learn about trends in cancer immunotherapy development, such as CAR-T, and tools for genomic, cellular, and proteomic research.

  • CRISPR Gene Editing

    CRISPR Gene Editing
    CRISPR enables researchers to edit their desired target genes efficiently and accelerate drug development.

  • Viral Vector Vaccine Development

    Viral Vector Vaccine Development
    The COVID-19 pandemic opened the door to expedited vaccine development using new technologies and therapies that have traditionally been used in other applications.